1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Postulated advantages of each treatment approach for patients with tandem lesions (acute stent placement versus no acute stent placement)
Potential Advantages of Acute Stent Placement Potential Advantages of No Acute Stent Placement Treatment of the causative embolic lesion and lower risk of stroke recurrence Lower risk of intracranial hemorrhage (avoidance of hyperperfusion, acute antiplatelet agents) Improvement of cerebral perfusion with potential attenuation of infarct progression Lower risk of iatrogenic artery-to-artery embolization during stent deployment Contribution to spontaneous intracranial clot lysis No risk of in-stent thrombosis Avoids delays in intracranial recanalization (if stent placement before thrombectomy) Lower risk of procedural bradycardia and hypotension from carotid baroreceptor activation with stent deployment